| Pharmaceutical active ingredients: |
| Fluorescein SodiumProparacaine Hydrochloride |
| Available forms, composition and doses of Fluoracaine: |
| Solution; Ophthalmic; Fluorescein Sodium 0.25%; Proxymetacaine Hydrochloride 0.5% |
| Fluoracaine medical category: |
| Human:DiagnosticsLocal anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01JA51 - Fluorescein, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AkornDioptic Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fluress | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Allergan; Abigo Medical; Advanced Medical Optics; Akorn; Pilkington Barnes Hind |
| Flurox | Fluorescein Sodium; Oxybuprocaine Hydrochloride | CYNACON / OCuSOFT |
| Oftan Flurekain | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Santen Pharmaceutical |
| Thilorbin | Fluorescein Sodium; Oxybuprocaine Hydrochloride | Alcon |
| Dioflur-P | Fluorescein Sodium; Proparacaine Hydrochloride | Dioptic Laboratories |
| Fluorocaine | Fluorescein Sodium; Proparacaine Hydrochloride | Medical Ophthalmics |
| Minims Proxymetacaine and Fluorescein | Fluorescein Sodium; Proparacaine Hydrochloride | Chauvin Pharmaceuticals |
| Caducid | Fluoresone | Istituto Farmacoterapico Italiano |
| APF Gel | Fluoride | Unidentified Pharmaceutical Company |
| Butler Prophy Paste | Fluoride | John O. Butler Company |